0001674416-16-000002.txt : 20161104 0001674416-16-000002.hdr.sgml : 20161104 20161104133119 ACCESSION NUMBER: 0001674416-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20161104 DATE AS OF CHANGE: 20161104 EFFECTIVENESS DATE: 20161104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-273840 FILM NUMBER: 161974548 BUSINESS ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 D 1 primary_doc.xml X0707 D LIVE 0001674416 CRISPR Therapeutics AG AESCHENVORSTADT 36 BASEL V8 SWITZERLAND 4051 41-61-228-7800 SWITZERLAND Inception Genomics AG None Corporation true 2013 Rodger Novak c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Executive Officer Director N. Anthony Coles c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Director Ali Behbahani c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Director Bradley Bolzon c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Director Simeon J. George c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Director Kurt von Emster c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Director Thomas Woiwode c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Director Pablo Cagnoni c/o CRISPR Therapeutics AG Aeschenvorstadt 36 Basel V8 SWITZERLAND 4051 Director Marc Becker c/o CRISPR Therapeutics, Inc. 200 Sidney Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Sven Ante Lundberg c/o CRISPR Therapeutics, Inc. 200 Sidney Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Samarth Kulkarni c/o CRISPR Therapeutics, Inc. 200 Sidney Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Tyler Dylan-Hyde c/o CRISPR Therapeutics, Inc. 200 Sidney Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Kala Subramanian c/o CRISPR Therapeutics, Inc. 200 Sidney Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Biotechnology Decline to Disclose 06c false 2016-10-20 false true false 0 35000000 35000000 0 false 1 0 0 0 false CRISPR Therapeutics AG /s/ Rodger Novak Rodger Novak Chief Executive Officer 2016-10-31